CON/217/RX4 = Supply of COBALT Drug Trial Requirements

Cumbria, Northumberland, Tyne & Wear NHS Foundation Trust · Closed

Buyer
Cumbria, Northumberland, Tyne & Wear NHS Foundation Trust
Status
Closed
Country
United Kingdom
Region
England
Sector
Manufacturing
Reference
FaT-ocds-h6vhtk-02c661
Published
2021-07-09
Deadline
2021-08-10

Tender summary

Cumbria, Northumberland, Tyne and Wear NHS Foundation Trust are seeking expressions of interest from capable bidders for the following opportunity: COmBining memantine And cholinesterase inhibitors in Lewy body dementia treatment Trial (COBALT) Introduction Cumbria, Northumberland, Tyne and Wear NHS Foundation Trust (CNTW) and The University of Melbourne (UoM), Australia have successfully bid for funding to run 2 National, multi-site, placebo controlled clinical trial assessing if adjunctive Memantine use in patients with Lewy Body Dementia (LBD) and Parkinson’s Disease Dementia (PDD) has any…

This is a public summary of a procurement notice. Dates and status reflect the notice held by BidScout; check the full notice before bidding.

Full tender details have a three-minute guest preview for open opportunities. AI insights require registration.

Register for full access

IT tenders · Construction tenders · Sitemap